Emerging Research

Around 25 years ago, the first human transplant using umbilical cord blood stem cells was performed. At the time, only one disease was treatable using cord blood stem cells. Today, cord blood stem cells can be used in the treatment of nearly 80 diseases and the list continues to develop. So what’s behind this growing number? Science.

Advancements in Science. Growing potential.

Countless hours of research drove the discovery of medical applications for cord blood stem cells.  And with 35,000 cord blood transplants performed worldwide, their therapeutic value today is clear.4 Great scientific minds continue to probe for new possibilities using cord blood stem cells and many have embarked on a new and exciting area of research known as regenerative medicine. In recent years a special stem cell type or Mesenchymal Stem Cells (MSCs), found in abundance in cord tissue, has been identified as a highly capable cell with immense therapeutic potential.19 Today’s research indicates that stem cells from cord blood and cord tissue may work differently to heal the body.

A cautionary note about cord blood and tissue research

Newborn stem cell research offers hope to many who are ill or concerned about risk factors. And research advancements provide valuable insight on the quest to answer, ‘Does it work?’, even when it doesn’t. The transfer of knowledge from lab to bedside takes time and the journey to validated findings is one of endurance, not speed. Rest assured, at ViaCord we ‘think big’ about the potential of cord blood and cord tissue stem cells and are committed to pushing the science forward. By collaborating with renowned academic institutions and participating in well-designed studies, we work hard to put babies and families in the best possible position for a healthy outcome.